Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Maintains Outperform on VMware, Lowers Price Target to $149

Raymond James analyst Simon Leopold maintains VMware (NYSE:VMW) with a Outperform and lowers the price target from $167 to $149.

byBenzinga Newsdesk

May 27, 2022

1 minute read

Raymond James analyst Simon Leopold maintains VMware (NYSE:VMW) with a Outperform and lowers the price target from $167 to $149.

Notable American Express Insider Makes $2.14 Million Sale

By Benzinga Insights

Today, 11:49 PM

Marc Gordon, Chief Information Officer at American Express (NYSE:AXP), made a large insider sell on September 10, according to a new SEC filing.

AXP

Pfizer Files Countersuit Against Moderna In Patent Litigation Over COVID-19 Vaccine

By Michael Horton

Today, 11:49 PM

-Reuters

BNTX

Analyst Ratings

4 Analysts Have This to Say About SciPlay

By Benzinga Insights

Today, 11:49 PM

Within the last quarter, SciPlay (NASDAQ:SCPL) has observed the following analyst ratings:

SCPL

Lucid Diagnostics Q4 Adj. EPS $(0.22) Down From $(0.19) YoY, Sales $300.00K

By Benzinga Newsdesk

Today, 11:49 PM

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.22) per share. This is a 15.79 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $300.00 thousand in

LUCD

Raymond James Maintains Outperform on VMware, Lowers Price Target to $149

Related Posts

Notable American Express Insider Makes $2.14 Million Sale

Pfizer Files Countersuit Against Moderna In Patent Litigation Over COVID-19 Vaccine

4 Analysts Have This to Say About SciPlay

Lucid Diagnostics Q4 Adj. EPS $(0.22) Down From $(0.19) YoY, Sales $300.00K